CF
NUVB icon

Corebridge Financial’s Nuvation Bio NUVB Stock Holding History

Corebridge Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-88,822
Closed -$156K – 1848
2025
Q1 		$156K Sell
88,822
-1,317
-1% -$3K ﹤0.01% 2217
2024
Q4 		$240K Sell
90,139
-6,804
-7% -$17.5K ﹤0.01% 2075
2024
Q3 		$222K Buy
96,943
+391
+0.4% +$1.19K ﹤0.01% 2172
2024
Q2 		$282K Buy
+96,552
New +$295K ﹤0.01% 2000

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Corebridge Financial's NUVB Position: Q2 2025 in Review

Corebridge Financial sold out of Nuvation Bio (NUVB) in Q2 2025, closing a stake of 88,822 shares — an estimated $156K sold.

Corebridge Financial first reported a position in NUVB in Q2 2024 and held it in 4 quarters. The position peaked at $282K in Q2 2024. 182 funds tracked by Wall St. Rank hold NUVB as of Q2 2025.

  • Corebridge Financial reported no remaining Nuvation Bio position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 88,822 Nuvation Bio shares in Q2 2025, an estimated $156K.
  • Corebridge Financial first reported a position in Nuvation Bio in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Nuvation Bio position peaked at $282K in Q2 2024.
  • 182 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.